Neoplasm Treatment - Argentina
Argentina- The Neoplasm Treatment market in Argentina is projected to witness a significant growth in revenue, reaching a staggering amount of US$1.44bn in 2024.
- This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 3.66%, leading to a market volume of US$1.72bn by 2029.
- When compared globally, it is worth noting that United States is anticipated to generate the highest revenue in this market, with an estimated amount of US$90.56bn in 2024.
- Argentina has seen a rise in the use of immunotherapy as a neoplasm treatment, offering new hope to cancer patients in the country.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
